611 related articles for article (PubMed ID: 12177271)
21. Gene therapy with human osteoprotegerin decreases callus remodeling with limited effects on biomechanical properties.
Ulrich-Vinther M; Schwarz EM; Pedersen FS; Søballe K; Andreassen TT
Bone; 2005 Dec; 37(6):751-8. PubMed ID: 16169783
[TBL] [Abstract][Full Text] [Related]
22. Pentamidine Inhibits Titanium Particle-Induced Osteolysis
Ihn HJ; Kim K; Cho HS; Park EK
Tissue Eng Regen Med; 2019 Jun; 16(3):265-273. PubMed ID: 31205855
[TBL] [Abstract][Full Text] [Related]
23. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
24. [Interleukin-4 and osteoprotegerin suppress polyethylene wear debris-induced osteolysis in a murine air pouch model].
Wang Y; Zhou R; Wu NN; Mou YQ; Li RD; Deng ZL
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Oct; 31(10):1709-13. PubMed ID: 22027773
[TBL] [Abstract][Full Text] [Related]
25. Cepharanthine ameliorates titanium particle-induced osteolysis by inhibiting osteoclastogenesis and modulating OPG/RANKL ratio in a murine model.
Liao L; Lin Y; Liu Q; Zhang Z; Hong Y; Ni J; Yu S; Zhong Y
Biochem Biophys Res Commun; 2019 Sep; 517(3):407-412. PubMed ID: 31376931
[TBL] [Abstract][Full Text] [Related]
26. Melittin Treats Periprosthetic Osteolysis in a Rat Model by Inhibiting the NF-kB Pathway and Regulating the Ratio of Receptor Activator of Nuclear Factor Kappa B Ligand/Osteoprotegerin.
Niu J; Bi F; Tian Q; Tian K
J Arthroplasty; 2024 Jul; 39(7):1845-1855. PubMed ID: 38336308
[TBL] [Abstract][Full Text] [Related]
27. Combination gene therapy targeting on interleukin-1β and RANKL for wear debris-induced aseptic loosening.
Wang H; Jia TH; Zacharias N; Gong W; Du HX; Wooley PH; Yang SY
Gene Ther; 2013 Feb; 20(2):128-35. PubMed ID: 22318091
[TBL] [Abstract][Full Text] [Related]
28. Blockade of XCL1/Lymphotactin Ameliorates Severity of Periprosthetic Osteolysis Triggered by Polyethylene-Particles.
Tian Y; Terkawi MA; Onodera T; Alhasan H; Matsumae G; Takahashi D; Hamasaki M; Ebata T; Aly MK; Kida H; Shimizu T; Uetsuki K; Kadoya K; Iwasaki N
Front Immunol; 2020; 11():1720. PubMed ID: 32849609
[TBL] [Abstract][Full Text] [Related]
29. Systemic osteoprotegerin gene therapy restores tumor-induced bone loss in a therapeutic model of breast cancer bone metastasis.
Chanda D; Isayeva T; Kumar S; Siegal GP; Szafran AA; Zinn KR; Reddy VV; Ponnazhagan S
Mol Ther; 2008 May; 16(5):871-8. PubMed ID: 18388919
[TBL] [Abstract][Full Text] [Related]
30. Notoginsenoside R1 suppresses wear particle-induced osteolysis and RANKL mediated osteoclastogenesis in vivo and in vitro.
Zhao S; Yan L; Li X; Zhang Z; Sun Y; Wang J
Int Immunopharmacol; 2017 Jun; 47():118-125. PubMed ID: 28384530
[TBL] [Abstract][Full Text] [Related]
31. Icariin protects against titanium particle-induced osteolysis and inflammatory response in a mouse calvarial model.
Shao H; Shen J; Wang M; Cui J; Wang Y; Zhu S; Zhang W; Yang H; Xu Y; Geng D
Biomaterials; 2015 Aug; 60():92-9. PubMed ID: 25985156
[TBL] [Abstract][Full Text] [Related]
32. TiAl
Wang Z; Deng Z; Gan J; Zhou G; Shi T; Wang Z; Huang Z; Qian H; Bao N; Guo T; Chen J; Zhang J; Liu F; Dong L; Zhao J
Acta Biomater; 2017 Jan; 48():489-498. PubMed ID: 27838463
[TBL] [Abstract][Full Text] [Related]
33. Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma.
Croucher PI; Shipman CM; Lippitt J; Perry M; Asosingh K; Hijzen A; Brabbs AC; van Beek EJ; Holen I; Skerry TM; Dunstan CR; Russell GR; Van Camp B; Vanderkerken K
Blood; 2001 Dec; 98(13):3534-40. PubMed ID: 11739154
[TBL] [Abstract][Full Text] [Related]
34. Naringin increases osteoprotegerin expression in fibroblasts from periprosthetic membrane by the Wnt/β-catenin signaling pathway.
Yang C; Liu W; Zhang X; Zeng B; Qian Y
J Orthop Surg Res; 2020 Dec; 15(1):600. PubMed ID: 33302980
[TBL] [Abstract][Full Text] [Related]
35. The effect of spinal instrumentation particulate wear debris. an in vivo rabbit model and applied clinical study of retrieved instrumentation cases.
Cunningham BW; Orbegoso CM; Dmitriev AE; Hallab NJ; Sefter JC; Asdourian P; McAfee PC
Spine J; 2003; 3(1):19-32. PubMed ID: 14589241
[TBL] [Abstract][Full Text] [Related]
36. Amentoflavone Inhibits Osteoclastogenesis and Wear Debris-Induced Osteolysis via Suppressing NF-κB and MAPKs Signaling Pathways.
Zhang Z; Zhao S; Li X; Zhuo X; Zhang W; Nie Q; Wang S; Yan L; Sun Y
Planta Med; 2018 Jul; 84(11):759-767. PubMed ID: 29301147
[TBL] [Abstract][Full Text] [Related]
37. Strontium ranelate reduces the progression of titanium particle-induced osteolysis by increasing the ratio of osteoprotegerin to receptor activator of nuclear factor-κB ligand in vivo.
Geng T; Sun S; Chen X; Wang B; Guo H; Zhang S; Jin Q
Mol Med Rep; 2018 Mar; 17(3):3829-3836. PubMed ID: 29257329
[TBL] [Abstract][Full Text] [Related]
38. Serum levels of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand as markers of periprosthetic osteolysis.
Granchi D; Pellacani A; Spina M; Cenni E; Savarino LM; Baldini N; Giunti A
J Bone Joint Surg Am; 2006 Jul; 88(7):1501-9. PubMed ID: 16818976
[TBL] [Abstract][Full Text] [Related]
39. Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
Croucher PI; Shipman CM; Van Camp B; Vanderkerken K
Cancer; 2003 Feb; 97(3 Suppl):818-24. PubMed ID: 12548581
[TBL] [Abstract][Full Text] [Related]
40. Evidence for a direct role of cyclo-oxygenase 2 in implant wear debris-induced osteolysis.
Zhang X; Morham SG; Langenbach R; Young DA; Xing L; Boyce BF; Puzas EJ; Rosier RN; O'Keefe RJ; Schwarz EM
J Bone Miner Res; 2001 Apr; 16(4):660-70. PubMed ID: 11315993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
